Medication info
Algas Tablets

Algas Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
HLB Pharmaceuticals Co., Ltd.
Appearance
White, round, film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201501584 · Approved 2015.03.25

This product's status changed to Expired on 2025.03.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.); prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
Usually, regardless of meals, take 2 tablets orally twice daily, in the morning and before bedtime. 1) Gastric and duodenal ulcers Take 2 tablets twice daily, or 4 tablets once daily before bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by taking 4 tablets twice daily, in the morning and before bedtime. The dose is the same for combination therapy to prevent ulcers caused by nonsteroidal anti-inflammatory drugs or gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily before bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 2 tablets twice daily or 4 tablets once daily before bedtime. The dose may be increased to 4 tablets 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
HLB Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.); prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcer
View approved original text

This medication is effective for gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, and gastroesophageal reflux disease. It is also used for conditions characterized by excessive gastric acid secretion, such as Zollinger-Ellison syndrome. It helps prevent ulcers that may occur after surgery and treat ulcers caused by NSAIDs (non-steroidal anti-inflammatory drugs). When administered before anesthesia, it is used to prevent Mendelson's syndrome. Overall, it protects the gastric mucosa and regulates gastric acid secretion, alleviating symptoms of various gastric diseases.

How to take

Adult dose

Usually, regardless of meals, take 2 tablets orally twice daily, in the morning and before bedtime. 1) Gastric and duodenal ulcers Take 2 tablets twice daily, or 4 tablets once daily before bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by taking 4 tablets twice daily, in the morning and before bedtime. The dose is the same for combination therapy to prevent ulcers caused by nonsteroidal anti-inflammatory drugs or gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily before bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 2 tablets twice daily or 4 tablets once daily before bedtime. The dose may be increased to 4 tablets 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or in those with poor kidney function. Additionally, it should not be administered to patients with a history of allergic reactions to this drug or its components, acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants, neonates, and patients on a potassium-restricted diet. Patients with impaired liver function, those who have had hypersensitivity reactions to medications, elderly patients, patients with a history of kidney disorders, and those taking NSAIDs should use this drug cautiously. Special caution is needed as it may mask symptoms of gastric cancer; patients with gastric ulcers or middle-aged patients with newly developed or changed indigestion symptoms should confirm the malignancy before use. Patients with gastric and duodenal ulcers who are Helicobacter pylori positive require treatment to eradicate the bacteria. Severe ICU patients, patients with hypophosphatemia, and those who have difficulty swallowing should also be monitored carefully. Severe allergic reactions such as anaphylactic shock may rarely occur during the use of this drug, so if symptoms arise, administration should be stopped immediately and medical attention sought. Symptoms of hypersensitivity may include skin rash, hives, angioedema, fever, and bronchospasm, so if these occur, the medication should be discontinued. Rare blood-related abnormalities such as leukopenia, thrombocytopenia, and elevation of serum enzymes may occur, and if symptoms are present, immediate medical attention should be obtained. Liver dysfunction may also occur rarely, so liver function tests should be monitored. Arrhythmias, vasculitis, and other heart-related issues have been reported very rarely, so symptoms related to the heart should be observed closely. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain, with stools possibly changing color, but this does not typically require special treatment. In severe cases or in elderly patients, neurological symptoms such as dizziness, drowsiness, confusion, seizures, insomnia, headache, and sensations of heaviness may occur, warranting caution. Endocrine side effects such as gynecomastia, excessive milk secretion, and erectile dysfunction have also been reported very rarely. Muscle pain, joint pain, and rhabdomyolysis-like musculoskeletal adverse reactions may occur rarely, so notify a healthcare professional immediately if symptoms arise. Skin-related abnormalities such as rashes, erythema multiforme, and alopecia may also occur. Long-term use of this drug should be avoided, and regular blood tests as well as liver and kidney function tests should be conducted during treatment, with changes to other medications if effectiveness is lacking. Avoid operating vehicles or dangerous machinery if dizziness or drowsiness occurs. There may be drug interactions, so inform a doctor or pharmacist about any other medications being taken. It is advisable for pregnant or breastfeeding women not to use this drug, and it is also preferable not to administer it to children. In cases of overdose, emergency measures such as vomiting or gastric lavage may be necessary, so caution is advised. This drug can reduce gastric acid secretion, which may promote bacterial growth in the stomach, requiring regular examinations including ophthalmic checks during long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 57 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • bone marrow hypoplasia
  • bone marrow aplasia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • seizures
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • illness sensation
  • anxiety
  • mental confusion
  • depression
  • hallucination
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • myoclonic jerks
  • gynecomastia
  • excessive lactation
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • stomatitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container that prevents air exposure and kept at a temperature between 1°C and 30°C at room temperature. Storing it this way helps maintain its efficacy and prevent degradation.

Appearance and packaging

Appearance

White, round, film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.